Copyright Reports & Markets. All rights reserved.

Global Plasma Fractionation Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Plasma Fractionation by Type
    • 1.3.1 Overview: Global Plasma Fractionation Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Plasma Fractionation Consumption Value Market Share by Type in 2024
    • 1.3.3 Albumin
    • 1.3.4 Immune Globulin
    • 1.3.5 Coagulation Factor
    • 1.3.6 Others
  • 1.4 Global Plasma Fractionation Market by Application
    • 1.4.1 Overview: Global Plasma Fractionation Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Plasma Fractionation Market Size & Forecast
  • 1.6 Global Plasma Fractionation Market Size and Forecast by Region
    • 1.6.1 Global Plasma Fractionation Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Plasma Fractionation Market Size by Region, (2020-2031)
    • 1.6.3 North America Plasma Fractionation Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Plasma Fractionation Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Plasma Fractionation Market Size and Prospect (2020-2031)
    • 1.6.6 South America Plasma Fractionation Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Plasma Fractionation Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Takeda
    • 2.1.1 Takeda Details
    • 2.1.2 Takeda Major Business
    • 2.1.3 Takeda Plasma Fractionation Product and Solutions
    • 2.1.4 Takeda Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Takeda Recent Developments and Future Plans
  • 2.2 CSL
    • 2.2.1 CSL Details
    • 2.2.2 CSL Major Business
    • 2.2.3 CSL Plasma Fractionation Product and Solutions
    • 2.2.4 CSL Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CSL Recent Developments and Future Plans
  • 2.3 Grifols
    • 2.3.1 Grifols Details
    • 2.3.2 Grifols Major Business
    • 2.3.3 Grifols Plasma Fractionation Product and Solutions
    • 2.3.4 Grifols Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Grifols Recent Developments and Future Plans
  • 2.4 Octapharma
    • 2.4.1 Octapharma Details
    • 2.4.2 Octapharma Major Business
    • 2.4.3 Octapharma Plasma Fractionation Product and Solutions
    • 2.4.4 Octapharma Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Octapharma Recent Developments and Future Plans
  • 2.5 Kedrion
    • 2.5.1 Kedrion Details
    • 2.5.2 Kedrion Major Business
    • 2.5.3 Kedrion Plasma Fractionation Product and Solutions
    • 2.5.4 Kedrion Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Kedrion Recent Developments and Future Plans
  • 2.6 LFB Group
    • 2.6.1 LFB Group Details
    • 2.6.2 LFB Group Major Business
    • 2.6.3 LFB Group Plasma Fractionation Product and Solutions
    • 2.6.4 LFB Group Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 LFB Group Recent Developments and Future Plans
  • 2.7 Biotest
    • 2.7.1 Biotest Details
    • 2.7.2 Biotest Major Business
    • 2.7.3 Biotest Plasma Fractionation Product and Solutions
    • 2.7.4 Biotest Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biotest Recent Developments and Future Plans
  • 2.8 BPL
    • 2.8.1 BPL Details
    • 2.8.2 BPL Major Business
    • 2.8.3 BPL Plasma Fractionation Product and Solutions
    • 2.8.4 BPL Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 BPL Recent Developments and Future Plans
  • 2.9 RAAS
    • 2.9.1 RAAS Details
    • 2.9.2 RAAS Major Business
    • 2.9.3 RAAS Plasma Fractionation Product and Solutions
    • 2.9.4 RAAS Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 RAAS Recent Developments and Future Plans
  • 2.10 CBPO
    • 2.10.1 CBPO Details
    • 2.10.2 CBPO Major Business
    • 2.10.3 CBPO Plasma Fractionation Product and Solutions
    • 2.10.4 CBPO Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 CBPO Recent Developments and Future Plans
  • 2.11 Hualan Bio
    • 2.11.1 Hualan Bio Details
    • 2.11.2 Hualan Bio Major Business
    • 2.11.3 Hualan Bio Plasma Fractionation Product and Solutions
    • 2.11.4 Hualan Bio Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Hualan Bio Recent Developments and Future Plans
  • 2.12 Tiantan Bio
    • 2.12.1 Tiantan Bio Details
    • 2.12.2 Tiantan Bio Major Business
    • 2.12.3 Tiantan Bio Plasma Fractionation Product and Solutions
    • 2.12.4 Tiantan Bio Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Tiantan Bio Recent Developments and Future Plans
  • 2.13 Shuanglin Bio
    • 2.13.1 Shuanglin Bio Details
    • 2.13.2 Shuanglin Bio Major Business
    • 2.13.3 Shuanglin Bio Plasma Fractionation Product and Solutions
    • 2.13.4 Shuanglin Bio Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Shuanglin Bio Recent Developments and Future Plans
  • 2.14 Boya Bio
    • 2.14.1 Boya Bio Details
    • 2.14.2 Boya Bio Major Business
    • 2.14.3 Boya Bio Plasma Fractionation Product and Solutions
    • 2.14.4 Boya Bio Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Boya Bio Recent Developments and Future Plans
  • 2.15 Yuanda Shuyang
    • 2.15.1 Yuanda Shuyang Details
    • 2.15.2 Yuanda Shuyang Major Business
    • 2.15.3 Yuanda Shuyang Plasma Fractionation Product and Solutions
    • 2.15.4 Yuanda Shuyang Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Yuanda Shuyang Recent Developments and Future Plans
  • 2.16 Weiguang Bio
    • 2.16.1 Weiguang Bio Details
    • 2.16.2 Weiguang Bio Major Business
    • 2.16.3 Weiguang Bio Plasma Fractionation Product and Solutions
    • 2.16.4 Weiguang Bio Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Weiguang Bio Recent Developments and Future Plans
  • 2.17 Nanyue Bio
    • 2.17.1 Nanyue Bio Details
    • 2.17.2 Nanyue Bio Major Business
    • 2.17.3 Nanyue Bio Plasma Fractionation Product and Solutions
    • 2.17.4 Nanyue Bio Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Nanyue Bio Recent Developments and Future Plans
  • 2.18 KM Biologics
    • 2.18.1 KM Biologics Details
    • 2.18.2 KM Biologics Major Business
    • 2.18.3 KM Biologics Plasma Fractionation Product and Solutions
    • 2.18.4 KM Biologics Plasma Fractionation Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 KM Biologics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Plasma Fractionation Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Plasma Fractionation by Company Revenue
    • 3.2.2 Top 3 Plasma Fractionation Players Market Share in 2024
    • 3.2.3 Top 6 Plasma Fractionation Players Market Share in 2024
  • 3.3 Plasma Fractionation Market: Overall Company Footprint Analysis
    • 3.3.1 Plasma Fractionation Market: Region Footprint
    • 3.3.2 Plasma Fractionation Market: Company Product Type Footprint
    • 3.3.3 Plasma Fractionation Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Plasma Fractionation Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Plasma Fractionation Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Plasma Fractionation Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Plasma Fractionation Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Plasma Fractionation Consumption Value by Type (2020-2031)
  • 6.2 North America Plasma Fractionation Market Size by Application (2020-2031)
  • 6.3 North America Plasma Fractionation Market Size by Country
    • 6.3.1 North America Plasma Fractionation Consumption Value by Country (2020-2031)
    • 6.3.2 United States Plasma Fractionation Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Plasma Fractionation Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Plasma Fractionation Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Plasma Fractionation Consumption Value by Type (2020-2031)
  • 7.2 Europe Plasma Fractionation Consumption Value by Application (2020-2031)
  • 7.3 Europe Plasma Fractionation Market Size by Country
    • 7.3.1 Europe Plasma Fractionation Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Plasma Fractionation Market Size and Forecast (2020-2031)
    • 7.3.3 France Plasma Fractionation Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Plasma Fractionation Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Plasma Fractionation Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Plasma Fractionation Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Plasma Fractionation Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Plasma Fractionation Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Plasma Fractionation Market Size by Region
    • 8.3.1 Asia-Pacific Plasma Fractionation Consumption Value by Region (2020-2031)
    • 8.3.2 China Plasma Fractionation Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Plasma Fractionation Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Plasma Fractionation Market Size and Forecast (2020-2031)
    • 8.3.5 India Plasma Fractionation Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Plasma Fractionation Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Plasma Fractionation Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Plasma Fractionation Consumption Value by Type (2020-2031)
  • 9.2 South America Plasma Fractionation Consumption Value by Application (2020-2031)
  • 9.3 South America Plasma Fractionation Market Size by Country
    • 9.3.1 South America Plasma Fractionation Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Plasma Fractionation Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Plasma Fractionation Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Plasma Fractionation Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Plasma Fractionation Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Plasma Fractionation Market Size by Country
    • 10.3.1 Middle East & Africa Plasma Fractionation Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Plasma Fractionation Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Plasma Fractionation Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Plasma Fractionation Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Plasma Fractionation Market Drivers
  • 11.2 Plasma Fractionation Market Restraints
  • 11.3 Plasma Fractionation Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Plasma Fractionation Industry Chain
  • 12.2 Plasma Fractionation Upstream Analysis
  • 12.3 Plasma Fractionation Midstream Analysis
  • 12.4 Plasma Fractionation Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Plasma Fractionation market size was valued at US$ 36350 million in 2024 and is forecast to a readjusted size of USD 59300 million by 2031 with a CAGR of 7.3% during review period.
    Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation. In this report, we mainly study the Blood Plasma Fractionation products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.
    Market Drivers:
    Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.
    Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.
    Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.
    Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
    Market Challenges:
    High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
    Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
    Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
    Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
    The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
    The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.
    North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.
    This report is a detailed and comprehensive analysis for global Plasma Fractionation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Plasma Fractionation market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Plasma Fractionation market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Plasma Fractionation
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Plasma Fractionation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Plasma Fractionation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Albumin
    Immune Globulin
    Coagulation Factor
    Others
    Market segment by Application
    Hospital
    Retail Pharmacy
    Other
    Market segment by players, this report covers
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio
    Nanyue Bio
    KM Biologics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Plasma Fractionation product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Plasma Fractionation, with revenue, gross margin, and global market share of Plasma Fractionation from 2020 to 2025.
    Chapter 3, the Plasma Fractionation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Plasma Fractionation market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma Fractionation.
    Chapter 13, to describe Plasma Fractionation research findings and conclusion.

    Buy now